Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
HCV-positive liver transplant cost-effective in patients without HCV
Modelling results from a recent study showed that transplantation of hepatitis C-positive livers into uninfected patients with preemptive direct-acting antiviral therapy was a cost-effective strategy and could improve health outcomes, especially in those with higher MELD scores.
Treatment-as-prevention only viable with expanded HCV coverage
Results of a modeling study showed that in dense urban settings with high prevalence of hepatitis C among people who inject drugs, HCV treatment-as-prevention strategies will have little impact over 10 years unless coverage is greatly expanded.
Log in or Sign up for Free to view tailored content for your specialty!
New York survey shows mortality, comorbidity risk higher in HCV vs. HBV
Results of a recent mortality profile of New York City residents with hepatitis C and hepatitis B showed that patients with HCV were significantly more likely to have HIV coinfection, hepatocellular carcinoma, and lower survival rates compared with HBV.
Nearly 25% of teens have asked their parents for a tattoo
Tattoos are becoming increasingly popular among teenagers, with nearly one-quarter of teens aged 16 to 18 years asking for parental approval; however, many parents are concerned about the risk for infection and the social stigma associated with body modification, according to a C.S. Mott Children’s Hospital National Poll.
HCV reinfection after SVR common in recent injection drug users
Population-level hepatitis C reinfection rates after direct-acting antiviral therapy were elevated among people who inject drugs due to ongoing exposure risk, according to a recently published study.
Tribute to Ted Eickhoff: Infectious disease practitioners as public health advocates
Ted Eickhoff understood the intersection of public health and the infectious disease practitioner, effectively using his editorial pulpit at Infectious Disease News to promote dialogue and discourse on the rapidly changing circumstances that would dictate public health policy. He recognized the ever-evolving microbial world’s impact on not only the individual patient, but on the community at large, and remained at the forefront, ensuring that infectious disease practitioners received needed information in a timely manner so they could remain staunch public health partners. A profession is traditionally defined by its common body of knowledge. As with the 1910 Flexner Report that proved revolutionary for medical education in the United States, the 1915 Welch-Rose report presented to the General Education Board of the Rockefeller Foundation outlined public health as a profession in which “Unity is to be found rather in the end to be accomplished. ... Public Health is not a single profession in the traditional sense and is best defined by its shared goals rather than its disparate means. Articulating who we are and what we do remains one of our greatest challenges.”
Post-HCV therapy liver cancer risk models reduce excess screening
Liver disease researchers recently published internally validated models that estimated the risk for hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C based on the presence of cirrhosis and sustained virologic response outcome.
Outcome Health partners with ALF to promote HCV screening guide
Outcome Health announced a partnership with the American Liver Foundation to launch a nationwide campaign to promote the recently updated hepatitis C screening recommendations and raise awareness of liver disease, according to a press release.
Resistance did not affect SVR rates in trials of Vosevi for HCV
Baseline resistance associated substitutions did not impact sustained virologic response among direct-acting antiviral-experienced patients who underwent hepatitis C therapy with Vosevi for 12 weeks, according to a recently published study.
WHO adds ravidasvir to HCV recommendation guidelines
The World Health Organization has added ravidasvir as a future pangenotypic direct-acting antiviral to the list of recommended therapies in their Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C, according to a press release.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read